Samsung Electronics announced that the Irregular Heart Rhythm Notification (IHRN) feature of the Samsung Health Monitor app has received FDA clearance. Together with the app’s existing on-demand Electrocardiogram (ECG) function, the IHRN feature proactively monitors heart rhythms suggestive of atrial fibrillation (AFib), right from their wrist.
Cardiovascular disease remains one of the world’s leading causes of death and AFib — a type of arrhythmia — is widely considered a warning sign for major cardiovascular issues that can increase the risk of stroke, heart failure and other cardiovascular complications. Moreover, some of AFib cases are asymptomatic or even silent, leaving people unaware of their risk.
That’s why Galaxy Watch offers tools to help users better understand their heart health using the Samsung BioActive Sensor, including on-demand ECG recording and HR Alert function that detects abnormally high or low heart rates. The addition of the new IHRN feature enables Galaxy Watch users to monitor another aspect of their health. The Irregular Heart Rhythm Notification feature will be available as part of the newly announced One UI 5 Watch, coming first to the upcoming Galaxy Watch devices later this year and later expanding to previous editions.
